Endocrine-Disrupting Chemicals (EDCs) – Implications for Human Health
A webinar discussion with Dr. Leo Trasande about his new paper, “Endocrine-disrupting chemicals: implications for human health."
Pediatrician and premiere expert on endocrine disruptors, Dr. Leonardo Trasande of NYU Langone Medical Center, addresses major everyday environmental exposures like PFAS, BPA, pesticides and phthalates, and associated adverse health effects such as reproductive disorders like cancer, learning disabilities, diabetes and obesity, and reduced birth weight, among others. Dr. Pete Myers of Environmental Health Sciences and Carnegie Mellon University moderated.
The webinar is hosted by Carnegie Mellon University’s Institute for Green Science.
Leo Trasande, MD, MPP
Professor, Department of Pediatrics
Professor, Department of Environmental Medicine
Professor, Department of Population Health
NYU Grossman School of Medicine
Leonardo Trasande, MD, MPP is an internationally renowned leader in children’s environmental health. His research focuses on identifying the role of environmental exposures in childhood obesity and cardiovascular risks, and documenting the economic costs for policy makers of failing to prevent diseases of environmental origin in children proactively. He also holds appointments in the Wagner School of Public Service and NYU’s College of Global Public Health. He is perhaps best known for a series of studies published in Lancet Diabetes and Endocrinology and the Journal of Clinical Endocrinology and Metabolism that document disease costs due to endocrine disrupting chemicals in the US and Europe of $340 billion and €163 billion annually, respectively.
Pete Myers, Ph.D.
Chief Scientist (EHS), Adjunct Professor of Chemistry (CMU), Environmental Health Sciences and Carnegie Mellon University
Pete Myers has worked on endocrine disruption science since 1990. Along with co-authors Dr. Theo Colborn and Dianne Dumanoski, Myers wrote “Our Stolen Future,” the first book (1996) for the general public about endocrine disruption. Dr. Myers is actively involved in primary research on the impacts of endocrine disruption on human health and interpreting the policy implications of scientific discoveries in the field. In 2018 he co-published with 5 other scientists the first-ever randomized controlled experiment administering BPA to adult human subjects. He is on the boards of the Science Communication Network and the Jenifer Altman Foundation and previously served as board chair of the H. John Heinz Center for Science, Economics and the Environment. Over the last several years he has received major national and international awards, including from the Endocrine Society and the National Institutes of Health.